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 Highly sensitive and unique biomarkers are needed for early cancer detection. 
In particular, biomarkers in biofluids can be useful in detecting the existence of 
a tumor early in the body.  The utility of biofluid markers for cancer detection 
can be enhanced when multiple biofluids are simultaneously biochemically 
analyzed in order to acquire complementary information for diagnostic 
purposes. This work aimed at investigating the universal human whole blood 
and saliva biomarkers for breast cancer screening using machine learning-
assisted Raman spectroscopy. Raman spectroscopy was performed in the 393 
– 2063 cm-1 region using 785 nm laser excitation. Machine learning-assisted 
Raman spectroscopy was implemented by performing principal component 
analysis, independent component analysis, and support vector machine 
modeling on the Raman spectra in order to extract the underlying multivariate 
relationships between the observed biochemical alterations. Ten spectral 
regions were determined: 612 ± 1.44 cm-1, 785 cm-1, 968 ± 2.02 cm-1, 1000 ± 
0.86 cm-1, 1248 cm-1, 1340 cm-1, 1371 ± 0.57 cm-1, 1448 ± 1.73 cm-1, 1500 ± 2.88 
cm-1, and 1661 ± 1.44 cm-1, which can be regarded as universal biomarkers of 
breast cancer using both whole blood and saliva samples. The diagnostic 
models based on principal component analysis followed by support vector 
machine achieved mean sensitivity of 95.83 ± 2.48%, specificity of 99.16 ± 
0.65%, and accuracy of 98.50 ± 0.65% when differentiating healthy blood 
samples from diseased blood samples. Further, this model yielded mean 
sensitivity of 73.0 ± 6.20%, specificity of 97.50 ± 0.67%, and accuracy of 93.66 
± 0.80% when differentiating the healthy saliva samples from diseased saliva 
samples. The determined biomarkers could be used to establish a spectral 
system for detection of breast cancer. Further work, including large sample 
sizes, has to be done to figure out how proteins and nucleic acids behave in 
their conformational states in human blood and saliva before translating the 
findings to actual clinical application.  
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1. Introduction 
Breast cancer is the most frequently diagnosed cancer in women, as well as the leading cause of 
cancer death [1]. The routine diagnostic procedures include the histopathological examination of 
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biopsy samples and imaging tests which are often subjective, time-consuming, costly [2] and 
generally applicable in revealing cancers at already advanced stages [3]. This emphasizes the 
importance of developing less intrusive, real time, highly sensitive, and cost-effective screening 
methods for patients in the early stages of cancer development. One such method may be based on 
Raman microspectroscopy due to its many advantages such as use of less harmful near-infrared 
radiation, being reagent free, is less intrusive, requires less sample preparation, has high resolution 
(≤ 1 µm) and minimally affected by water bands [4]. 
In the last decades, preference of liquid biopsy, for example, blood and saliva to tissue biopsy in 
biological studies has generated interest in biomedical sciences. Biofluids have distinct properties 
that can be objectively assessed and tested as measures of both natural and pathogenic biologic 
processes - so-called biomarkers [5]. In oncology, the fluid biomarkers would be components in 
patient’s fluids that reveal the presence of cancer. This includes macromolecules that originate from 
tumor cells, for example, lipids, proteins, RNA, microRNA, and DNA [6]. Other fluid biomarkers 
include circulating cells such as circulating tumor cells, immune cells, stromal cells, and endothelial 
cells [5], [6]. 
The majority of tumors are vascularized; hence cancer biomarkers can be shed into the bloodstream 
[5]. Therefore, blood as one of the major fluids would be convenient for cancer biosignature 
detection. This convenience is further enhanced by its ease of availability, already established 
collection and ethical protocols, and the ability to replicate the test as many times as required to 
monitor disease progression or therapeutic response [5], as observed in reported breast cancer 
Raman studies [3], [7], [8]. Previous blood-based Raman studies on breast cancer observed Raman 
spectral differences in healthy and diseased breast cancer samples can be mainly attributed to 
biochemical changes of DNA, proteins, and lipids [3], [7], [8], [9].  However, it should be noted that 
many compounds found in blood, for example, growth factors, hormones, antibodies, and enzymes 
are also found in saliva. These compounds can move from bloodstream into salivary glands through 
processes of ultrafiltration, passive diffusion, or active transportation  [10]. Using saliva for cancer 
diagnosis would be relatively practical because of its noninvasive safe collection and high-speed 
sampling [10]. Indeed, transcriptomic and proteomic studies aimed at discovering and pre-validating 
saliva biomarkers for the noninvasive detection of breast cancer have largely shown salivary proteins 
can be prognostic markers for breast cancer screening [11].  
There are already two Raman studies available in literature in which biochemical components of 
salivary proteins were found significantly important for noninvasive discrimination of various grades 
of breast tumors [12], [13], but these studies do not focus on utility of salivary nucleic acids, lipids, 
and carbohydrates biochemical alterations for breast cancer diagnostics. However, it should be noted 
that reliability of using biofluids for disease diagnostics is a major challenge in Raman spectroscopy. 
For instance, the biomarker levels in saliva and biofluids exist in very low  concentrations [5], [14] 
well below the detection limits of most analytical spectroscopic techniques, including Raman. 
Therefore, the underlying biomarker alterations in healthy and diseased samples can be easily 
understood when Raman microspectroscopy is combined with machine learning techniques. 
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Machine learning techniques are intelligent computational methods for extracting maximum 
analytical information from measured data [15]. To achieve better diagnostic accuracies in cancer 
diagnostics, optimized machine learning techniques may be used to identify, isolate, amplify and 
process the subtle analyte peaks. This enhances sensitivity, accuracy, precision and speedy non-
destructiveness for in situ and in vitro diagnostic capabilities of Raman microspectroscopy. 
 
Currently, there is a lack of research interrogating universal whole blood and saliva Raman 
biomarkers for breast cancer screening. Therefore, this study set out to determine the universal 
prominent biochemical spectral marker differences in the whole blood and saliva samples of healthy 
and breast cancer patients using Raman spectroscopy and machine learning techniques. The singular 
value decomposition principal component analysis [16] and independent component analysis [17] 
were used as unsupervised methods for the multivariate exploration of primary sources of 
heterogeneity in spectral data sets. The support vector machine [18] was added as a supervised 
condition on the principal component analysis to give underlying spectral features more weight in 
the classification. The support vector machine classifier's output was evaluated using the overall error 
rate estimate from cross-validation and the receiver operating characteristic parameters. 
2. Materials and methods 
2.1 Blood and saliva sampling 
Whole blood and saliva were taken from the consenting 20 breast cancer patients and 23 healthy 
volunteers, all-female, at Kenyatta National Hospital, Kenya. To take part in the study, all of the 
participants signed a written consent form. This study was approved by the Kenyatta National 
Hospital-University of Nairobi Ethics and Research Committee (ERC certificate number: P112 / 03 / 
2018).  About 2 mL volumes of non-stimulated saliva and peripheral venous blood were collected 
from participants during morning hours. For blood samples, ethylenediaminetetraacetic acid was 
used as an anticoagulation agent, and stored at -20oC. Saliva was centrifuged at 6,500 revolutions per 
minute for 10 minutes to remove the food debris and oral mucous epithelial cells, and stored at -4oC.  
Based on histological pathological reports, the samples were categorized according to the reported 
level of breast malignancy in recruited patients - healthy (non-malignant), stage 1 (early-stage 
cancer), stage 2 (the cancer tumor has increased in size and has most likely spread to surrounding 
tissues or lymph nodes), and stage 3 (metastatic) cancer. 
2.2 Raman spectroscopy measurements 
A 10 µl aliquot was deposited onto conductive silver paint smeared substrates. Raman spectra were 
collected using a confocal Raman system from Seki Technotron Corporation, Japan. Raman 
measurements were performed in the 393-2063 cm-1 region with a 785 nm excitation laser, an 
exposure time of 120 seconds, and a spectral resolution of 1.35 cm-1 using the microscope's 80x 
objective. The excitation beam’s measured spot size was ≈ 31.25 µm. Spectral calibration was 
performed using a silicon semiconductor at 520.5 cm-1 band. About 15-20 spectra were measured 
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from five random points for each sample to obtain a mean spectrum. 
  
2.3 Spectral analysis 
2.3.1 Data preprocessing  
The analysis of measured spectra was performed in the 500-1800 cm-1 region, the considered 
fingerprint region for biological specimens [19]. Data denoising, smoothing, normalization, and 
baseline restoration were performed to remove artificial interference during the sample preparation 
and spectral acquisition [3], [7], [8], [9]. Spectral smoothing and autofluorescence background 
subtraction were done using the Vancouver algorithm based on the fifth-order polynomial fitting 
method [20].  Spectra were normalized to the CH2 deformation band near 1445 cm-1, using the 
OriginLab software.  
 
2.3.2 Multivariate statistical analysis of biomarkers alterations in whole blood and saliva for 
breast cancer diagnostics 
The preprocessed Raman spectra of healthy and diseased samples were combined to form single 
matrices, that is, 𝑋𝑤𝑥𝑛 where 𝑤 and 𝑛  represented total number of wavenumbers and spectra, 
respectively. For whole blood samples, three matrices labeled stage1 (X781 x 518), stage2 (X781 x 573), and 
stage3 (X781 x 671) were obtained, while matrices for saliva samples were stage1 (X781 x 559), stage2 (X781 
x 611), and stage3 (X781 x 775). The subscripts 1, 2, and 3 identified the stages of breast malignancy. To 
investigate the universal prominent spectral markers amongst whole blood and saliva samples, all 
the six matrices were combined into one spectral matrix (X781 x 3707) then subjected to independent 
component analysis by maximum likelihood fast fixed-point estimation algorithm. First, the algorithm 
worked by mean centering and whitening the spectral data, then followed by several iterations until 
convergence leading to determination of independent components was attained. The independent 
component analysis algorithm was based on the following expression [21]:  
 
𝑊+ = 𝑊 + 𝑑𝑖𝑎𝑔(𝛼𝑖)[𝑑𝑖𝑎𝑔(𝛽𝑖) + 𝐸{𝑔(𝑦)𝑦
𝑇}]𝑊                            (2.1) 
 
where 𝑦 = 𝑊𝑥,  𝛽𝑖 = −𝐸{𝑦𝑖𝑔(𝑦𝑖)}, and 𝛼𝑖 = −1/(𝛽𝑖 − 𝐸{𝑔
′(𝑦𝑖)}. In this case, the matrix  𝑊 needs 
to be orthogonalized after every step in a symmetrical manner. The convergence speed can be 
optimized by careful choice of matrices 𝑑𝑖𝑎𝑔(𝛼𝑖) and 𝑑𝑖𝑎𝑔(𝛽𝑖). In this study, the performance of the 
method was optimized by choosing a suitable nonlinearity 𝑔, where the nonlinearity 𝑔 function; 
𝑔(𝑢) = 𝑢3 was chosen due to its optimal performance. The decorrelation approach based on 
deflation technique was used where the independent components were estimated one-by-one. 
Moreover, the stabilized capability of the fixed-point algorithm was incorporated to ensure algorithm 
convergence. The maximum number of iterations were set at 1000.  
For discriminating between Raman spectral data sets, singular value decomposition principal 
component analysis by cross-validation [16] followed by support vector machine [18] was used. With 
singular value decomposition principal component analysis, three matrices; 𝑈 representing scores, 𝑆 
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representing scores’ size, and 𝑉 representing loadings were obtained,  according to the following 
equation [22]:  
 
𝑀𝑚𝑛 = 𝑈𝑚𝑚𝑆𝑚𝑛𝑉𝑛𝑛
𝑇                   (2.2) 
where 𝑈𝑇𝑈 = 1; 𝑉𝑇𝑈 = 1, subscripts m, and n represented number of samples and wave numbers, 
respectively. In this study, matrices 𝑈, 𝑆, 𝑉 yielded information regarding spectra discrimination, 
number of principal components, and the wavenumbers, respectively. 
 
For support vector machine, the general fitting function used was [23]: 
𝑓(𝑥) = ∑ 𝛼𝑖𝑦𝑖
𝑛
𝑖=1
𝐾(𝑥, 𝑥𝑖) + 𝛽𝑜                (2.3) 
where 𝐾(𝑥, 𝑥𝑖) is a kernel function; 𝑥𝑖  is the training sample eigenvector; and 𝑥 is the recognizing 
sample eigenvector [18]. The parameter 𝛼𝑖 is restricted to 0 ≤ 𝛼𝑖  ≤ 𝐶 and can be estimated by 
maximizing a Lagrangian, while parameter 𝐶 is the cost parameter that determines the amount of 
regularization, that is,  the classification error term [24]. In this study, we used the linear and radial 
basis support vector machines models based on equations (2.4) and (2.5), respectively [18], [23].  
𝐾(𝑥, 𝑥𝑖) = 𝑥 ∙ 𝑥𝑖                                             (2.4) 
𝐾(𝑥, 𝑥𝑖) = exp(−𝛾‖𝑥 − 𝑥𝑖‖
2)                  (2.5) 
The data analysis looked for the best function parameter 𝛾, as well as the best regularization 
parameter, 𝐶, for the efficient optimization process. The optimal 𝛾 and 𝐶 values were sorted in 
such a way that the effect was sufficient to create a decision surface without misclassifying the 
training set, hence reducing over-prediction. The 𝛾 and 𝐶 were obtained from the grid search for 
the highest cross-validation accuracy. In order to increase model accuracy, the 10 folds cross-
validation was used during data analysis.  
The linear and radial basis support vector machines models based on 5 to 10 principal components, 
cost = 100, and kernel parameters = 0.57 to 0.8, were used to generate the scatterplots of the 
control and diseased groups. To verify the effectiveness of the support vector machine diagnostic 
models in predicting diseased and healthy samples, two parameters; sensitivity and specificity 
were calculated. In this study, the ability of a test method to detect disease in diseased subjects 
was described by sensitivity parameters, while the ability to detect the absence of disease in 
healthy subjects was described by specificity parameters [9]. All multivariate analysis procedures 
were done in the MATLAB 2018b scripting environment.  
3. Results and Discussions 
The photomicrographs of typical blood and saliva samples taken at 50x magnification are shown in 
Figure 1 (a) and 1 (b), respectively. The characteristic pinkish-red color of the blood smear can be 
seen, a factor attributed to hemoglobin due to iron compounds. The picture of saliva depicts 
crystalline structures conjoined with each other in a tree or fern-like shape from the center of the 
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drop, as shown in Figure 1 (b). Other research [25] has indicated that morphological changes in 
dried oral saliva fluid are an indicator of quantitative and consistency molecular composition 
deviation.  
 
For independent component analysis, 10 eigen vectors (variance ≈ 98%) of spectral datasets were 
fed to the maximum likelihood fast fixed-point estimation algorithm. Three spectra; also termed 
as independent components were obtained, all shown in Figures 1 (c), (d) and (e). These 
independent components revealed the positive as well as negative peaks’ positions that explained 
the wavelengths representing biomarkers that could be associated with breast cancer. 
 
Figure 1. The photomicrographs of (a) dried blood sample, (b) dried saliva sample, and (c), (d), (e) the first 
three independent components that reveal breast cancer markers’ wavelengths. 
In addition, the difference spectra between the normalized mean baseline corrected spectrum of 
diseased samples (n = 20) and that of healthy samples (n = 23) were determined and plotted. The 
difference spectrum of blood and saliva samples are shown in Figure 2(a) and Figure 2 (b), 
respectively. The positive bands in the difference spectrum explained biochemical changes found in 
higher concentrations in breast cancer samples, while negative bands explained biochemical 
(e) (d) 
(c) (a) (b) 
Laser spot 
Laser spot 
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changes found in higher concentrations in healthy samples. The biochemical assignments of peaks 
were done in accordance with the Raman spectroscopy of tissues, body fluids, or bio-molecules as 
reported in the literature. This was done in consideration of position and possible wavelength 
differences of each particular Raman band. Due to possibility of varying detection conditions and 
experimental errors, the Raman bands within ± 10 cm-1 were considered to represent the same 
Raman peak [26]  
 
 
 
Figure 2. The difference Raman spectrum of (a) whole blood and (b) saliva samples. 
It can be seen that the first and second independent components revealed a peak at 555 cm-1. This 
spectral marker pointed to the presence of biochemical changes due to nucleic acid bases which 
include adenine, thymine, uracil, and guanine [27]. This band is also observed as a positive peak in 
the difference spectrum of blood samples in Figure 2 (a) but blue shifted to 561 cm-1, and can 
therefore be associated with specific biochemical changes occurring in blood samples of diseased 
patients. This finding imply there was pronounced biochemical changes due to nucleic acid 
components in whole blood samples of breast cancer patients. Examination of the first and third 
independent components showed strong peaks at 1197 cm-1 and 1187 cm-1, respectively. This peak 
is also observed at 1197 cm-1 as a positive peak in the difference spectrum of saliva samples in Figure 
2 (a). These markers are linked to the presence of anti-symmetric phosphate vibrations associated 
with nucleic acids compounds [3], [27], indicating that changes in salivary nucleic acid components 
were a dominant factor during breast cancer progression. It is observed the 1473 cm-1 and 1478 cm-
1 peaks are pronounced bands in the first and third independent components, respectively. These 
bands indicated presence of CH2 and CH3 deformations associated with lipids and collagen proteins 
[28], [29], though it is unclear if the biochemical changes occurred in the healthy or diseased 
samples. Although the 1416 and 1429 cm-1 peaks had > ± 10 cm-1 difference, both bands can be 
attributed to CH2 scissoring vibrations of lipids in healthy samples [7], [29], as evidenced  in negative 
spectrums of  Figures 2(a) and 2(b). Further analysis of all independent components revealed 
presence of mixed biochemical alterations due changes arising from nucleotide conformations at 
(a) (b) 
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628 cm-1, 668 cm-1, 745 cm-1, 1141 cm-1, 1247 cm-1, 1257 cm-1, 1324 cm-1, 1337 cm-1 [3], [27], [28], 
[29], [30],  tryptophan, tyrosine and phenylalanine proteins at 1002 cm-1, 1171 cm-1, 1247 cm-1, 1337 
cm-1, 1541 cm-1, 1552 cm-1, 1618 cm-1, 1637 cm-1 [7], [9], [27], [30], phospholipids at 745 cm-1, 1324 
cm-1, and saccharides  at 846 cm-1, 1115 cm-1 [27], [30]. It can therefore be concluded that 
alterations of nucleic acids and proteins were predominant in whole blood and saliva of healthy and 
breast cancer patients.  
To better understand the biochemical alterations and their differences in the studied samples, the 
spectral differences of whole blood and saliva bio-samples of the breast cancer group and the 
healthy group were compared. In consideration that the focus of this study was to determine the 
universal prominent biochemical spectral marker differences in the whole blood and saliva samples 
of healthy and breast cancer patients, we examined the difference spectrum of blood and saliva 
samples in Figures 2 (a) and 2 (b). Ten major peaks at the wavelengths 612 ± 1.44 cm-1, 785 cm-1, 
968 ± 2.02 cm-1, 1000 ± 0.86 cm-1, 1248 cm-1, 1340 cm-1, 1371 ± 0.57 cm-1, 1448 ± 1.73 cm-1, 1500 ± 
2.88 cm-1, and 1661 ± 1.44 cm-1 were identified. We consider these bands to be the universal 
spectral markers that differentiated diseased and healthy groups using both whole blood and saliva 
samples. These Raman peaks were attributed to proteins and nucleic acid bases alterations [3],  [7], 
[9], [27], [30]. The protein bands were based on aromatic amino acids which include tryptophan, 
phenylalanine, and tyrosine, while nucleic acid alterations were mainly due to the nucleic acid bases 
of adenine, guanine, thymine and cytosine. 
Examination of Figure 2(a) and 2(b) shows the peak intensities were greater for the breast cancer 
group than for the control group at 1371 ± 0.57 cm-1 and 1500 ± 2.88 cm-1, while the bands at 1248 
cm-1, 1340 cm-1, 1448 ± 1.73 cm-1, and 1591 ± 4.04 cm-1 were more intense in the spectra of control 
patients than for the breast cancer group. It can be concluded that nucleic acid levels were greater 
in blood and saliva samples from breast cancer patients as compared to the control group. Other 
serum-based studies have shown spectral features of nucleic acids points to presence and 
progression of breast cancer [3], [7]. In contrast, lipids, amide and phenylalanine protein levels were 
greater in blood and saliva samples from control patients as compared to the diseased group. This is 
in agreement with previous studies [7], [8], [31] where spectral markers attributed to biochemical 
changes of proteins and lipids at 1340 cm-1 and 1440-1460 cm-1 were found more intense in the 
spectra of control patients than for the breast cancer group. It is also noted that biochemical 
alterations corresponding to cholesterol esters at 612 ± 1.44 cm-1, phenylalanine  at 1000 ± 0.86 cm-
1, and amide I at 1661 ± 1.44 cm-1 were prominent in blood samples of breast cancer patients and in 
saliva samples of control patients, which agrees with other studies [9], [31]. Similarly, biochemical 
changes due to ring breathing modes in the nucleic acid bases at 785 cm-1, proteins and nucleic acids 
at 968 ± 2.02 cm-1, and glycogen at 1141 ± 3.17 cm-1 were predominant in saliva samples of breast 
cancer patients and blood samples of control patients. Detailed Raman assignments regarding other 
Raman markers in Figures 2(a) and 2 (b) are provided elsewhere [27], [28], [29], [30].  
Multivariate analysis based on support vector machine algorithm benefits from feature extraction 
techniques such as principal component analysis, which serves to reduce the curse of dimensionality 
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[7]. In this study, 5 to 10 principal components were found suitable for developing an efficient 
support vector machine diagnostic model. Furthermore, classification errors were found to decrease 
as the number of principal components increased, implying that the remaining number of principal 
components accounted for a substantial portion of the variance, which explained the most significant 
biochemical information [32]. The diagnostic results of singular value decomposition principal 
component analysis followed by the selected support vector machine models are shown in Table 1.  
Table 1. Diagnostic results of singular value decomposition principal component analysis followed by support 
vector machine diagnostic model on the Raman spectra of whole blood and saliva samples from healthy and 
breast cancer patients 
     Blood        Saliva 
Disease      SVM          Accuracy    Sensitivity    Specificity        Accuracy     Sensitivity   Specificity 
status         function          
Stage 1       Linear         100%           100%            100%                94%          46%               100%    
        RBF             100%            98%              100%                94%          69%               97%            
Stage 2       Linear         100%           100%            100%                94%          77%               98%      
        RBF             100%            98%              100%                94%          78%               98%      
Stage 3       Linear         93%              84%               96%                 90%                76%              95%       
        RBF             98%              95%               99%                 96%           92%              97%         
Abbreviations: RBF, Radial basis function; SVM, support vector machine; Stage 1, early-stage cancer;  
stage 2, cancer tumor has increased in size and has most likely spread to surrounding tissues or lymph 
nodes;  Stage 3, metastatic cancer.  
It can be seen that various values of diagnostic accuracy, sensitivity, and specificity were achieved 
depending on the samples and SVM functions in consideration. The developed SVM model achieved 
mean sensitivity of 95.83 ± 2.48%, specificity of 99.16 ± 0.65%, and accuracy of 98.50 ± 0.65% when 
differentiating healthy blood samples from diseased blood samples. Similarly, the SVM model yielded 
mean sensitivity of 73.0 ± 6.20%, specificity of 97.50 ± 0.67%, and accuracy of 93.66 ± 0.80% when 
differentiating the healthy saliva samples from diseased saliva samples. These results confirm the 
outstanding accuracy of the principal component analysis followed by support vector machine 
diagnostic algorithm for breast cancer detection.  
The sensitivity and specificity diagnostic parameters were greater when blood spectral data sets were 
used for diagnosis, indicating there was a reasonably good differentiation of the healthy and diseased 
sample’s spectra. The radial basis support vector machine kernel model performed better than the 
linear support vector machine kernel model in diagnosing late breast malignancy. This finding implies 
that the linear separable characteristic nature of spectral datasets [33] decreased with malignancy, 
hence the radial basis function was appropriately useful for handling non-linear data [34], leading to 
better diagnostic accuracy. Moreover, support vector machine model based on radial basis function 
had greater sensitivity diagnostic parameters, particularly in diagnosing breast cancer based on saliva 
samples. It should be noted that, in comparison to linear kernels which are parametric functions, 
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radial basis function is a squared exponential function that is a non-parametric function. The non-
parametric function defines a function space that is a lot larger than that of the linear kernel or the 
polynomial kernel, and can therefore be viewed as powerful as an infinite order polynomial kernel 
[34]. Therefore, the good diagnostic performance of radial basis kernel function in our study can be 
attributed to its nonparametric capability in handling complex data [33], [34]. This makes it suitable 
for handling a high degree of collinearity in the spectroscopic datasets.   
4. Conclusion 
The spectral analysis of blood and saliva spectrum revealed ten wavelengths attributed to proteins 
and nucleic acid markers at 612 ± 1.44 cm-1, 785 cm-1, 968 ± 2.02 cm-1, 1000 ± 0.86 cm-1, 1248 cm-1, 
1340 cm-1, 1371 ± 0.57 cm-1, 1448 ± 1.73 cm-1, 1500 ± 2.88 cm-1, and 1661 ± 1.44 cm-1, which can be 
regarded as universal dominant biomarkers of breast cancer. The diagnostic models based on 
principal component analysis followed by support vector machine achieved mean sensitivity of 95.83 
± 2.48%, specificity of 99.16 ± 0.65%, and accuracy of 98.50 ± 0.65% when differentiating healthy 
blood samples from diseased blood samples. The same model yielded mean sensitivity of 73.0 ± 
6.20%, specificity of 97.50 ± 0.67%, and accuracy of 93.66 ± 0.80% when differentiating the healthy 
saliva samples from diseased saliva samples. The overall diagnostic accuracies of radial basis support 
vector machine kernel model were greater than that of linear support vector machine classifier 
models, proving that the diagnostic performance of radial basis function is superior to that of a linear 
function in support vector machine algorithms. The findings of this study show that Raman 
spectroscopy combined with multivariate analysis diagnostic algorithms has a lot of potential for non-
invasive, label-free breast cancer detection using whole blood and saliva samples.  
Acknowledgments 
We acknowledge the Swedish International Development Cooperation Agency (SIDA), through the 
International Science Programme (ISP), Uppsala University, for financial support. The first author 
thanks the National Research Foundation of Kenya (NRF) for financial support, and Peninah Kabethi 
(Kenyatta National Hospital) for patient recruitment.  
References 
[1] A. Bouzalmat and J. Kharroubi, “Comparative Study of PCA, ICA, LDA using SVM Classifier,” Emerging Technologies 
in web Intelligence, vol. 6, no. 1, pp. 64–68, 2014. 
[2] A. Chandra, S. Talari, Z. Movasaghi, and S. Rehman, “Raman Spectroscopy of Biological Tissues,” Applied 
Spectroscopy Review, vol. 50, no. 1, pp. 46–111, 2015. 
[3] A. Hyvärinen, and E. Oja, “Independent Component Analysis: Algorithms and Applications,” Neural Networks, vol. 
13, no. 4–5, pp. 411–430, 2000. 
[4] A. J. Freddie Bray, J. Ferlay, I. Soerjomataram, R. L. Siegel, and L. A. Torre, “Global cancer statistics 2018 : GLOBOCAN 
Estimates of incidence and mortality worldwide for  36 Cancers in 185 Countries,” Cancer Journal of Clinicians, 
vol. 68, pp. 394–424, 2018. 
[5] B. Han, Y. Du, T. Fu, Z. Fan, S. Xu, C. Hu, L. Bi, T. Gao, H. Zhang, and W. Xu, “Differences and Relationships Between 
Normal and Atypical Ductal Hyperplasia, Ductal Carcinoma in situ, and Invasive Ductal Carcinoma Tissues in the 
Breast Based on Raman Spectroscopy,” Applied Spectroscopy, vol. 71, no. 2, pp. 300–307, 2017. 
 
Concurrent Machine learning Assisted Raman Spectroscopy of Whole Blood and Saliva for Breast Cancer 
Diagnostics 
55 
[6] C. B. Y. Cordella, “PCA : The Basic Building Block of Chemometrics,” pp. 1–46, 2012. 
[7] E. Vargas-Obieta, J. C. Martínez-Espinosa, B. E. Martínez-Zerega, L. F. Jave-Suárez, A. Aguilar-Lemarroy, and J. L. 
González-Solís, “Breast cancer detection based on serum  sample surface enhanced Raman spectroscopy,” 
Lasers in Medical Science, vol. 31, no. 7, pp. 1317–1324, 2016. 
[8] H. Byrne, L. Kerr, and B. M. Hennelly, “Optimal choice of sample substrate and laser wavelength for Raman 
spectroscopic analysis of biological specimen,” Analytical Methods, vol. 7, no. 1, pp. 5041–5052, 2015. 
[9] H. Chen, Z. Lin, and C. Tan, “Cancer Discrimination Using Fourier Transform Near-Infrared Spectroscopy with 
Chemometric Models,” Journal of Chemistry, vol. 2015, pp. 1–9, 2015. 
[10] H. F. Nargis, H. Nawaz, A. Ditta, T. Mahmood, M.I. Majeed, N. Rashid, M. Muddassar, H.  N. Bhatti, M. Saleem, 
K. Jilani, F. Bonnier, and H.J. Byrne, “Raman spectroscopy of blood plasma samples from  breast cancer patients 
at different stages,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, vol. 222, p. 117210, 
2019. 
[11] I. Rehman, Z. Movasaghi, and S. Rehman, “Vibrational spectroscopy for tissue analysis,” CRC Press, pp. 214–287, 
2013. 
[12] I. T. Jolliffe, Principal Component Analysis, Second Edition. New York: Springer - Verlag, pp. 111-118, 2002. 
[13] J. De Gelder, K. De Gussem, P. Vandenabeele, and L. Moens, “Reference database of Raman spectra of biological 
molecules,” Raman Spectroscopy, vol. 38, pp. 1133–1147, 2007. 
[14] J. Zhao, H. Lui, D. I. McLean, and H. Zeng, “Automated Autofluorescence Background Subtraction Algorithm for 
Biomedical Raman Spectroscopy,” Applied Spectroscopy, vol.  61, no. 11, pp. 1225–1232, 2007. 
[15] K. J. Martin, M. V Fournier, G. P. V. Reddy, and A. B. Pardee, “A need for basic Research on fluid-based early detection 
biomarkers,” Cancer Research, vol. 70, pp. 5203–5207, 2010. 
[16] K. Varmuza, and P. Filzmoser, Introduction to multivariate statistical analysis in Chemometrics. Boca Raton: CRC 
Press, pp. 1-20, 2008.  
[17] L. McCreely, Raman Spectroscopy for Chemical Analysis. John Wiley and Sons, Ltd, pp. 73-83, 91-92, 2001. 
[18] M. Bilal, S. Tabassum, M. Saleem, H. Mahmood, U. Sarwar, H. Bangush, F. Munir, M. A.  Zia, M.  Ahmed, S. 
Shahzada, and E. U. Khan, “Optical Screening of Female Breast Cancer from Whole Blood Using Raman 
Spectroscopy,” Applied Spectroscopy, vol. 71, no. 5, pp. 1004-1013, 2017. 
[19] M. Boiret, D. N. Rutledge, N. Gorretta, Y. M. Ginot, and J. M. Roger, “Application of independent component analysis 
on Raman images of a pharmaceutical drug product: pure spectra determination and spatial distribution of 
constituents,” Journal of Pharmaceutical and Biomedical Analysis, Elsevier, vol. 90, pp. 78–84, 2014. 
[20] M. J. Baker, S. R. Hussain, L. Lovergne, V. Untereiner, C. Hughes, R. A. Lukaszewski, G. Thie´finbg, and G. D. 
Sockalingum, “Developing and understanding biofluid vibrational spectroscopy: A critical review,” Chemical Society. 
Reviews, vol. 45, no. 7, pp. 1803–1818, 2016.  
[21] M. V. P. Chowdary, K. K. Kumar, J. Kurien, S. Mathew, and C. M. Krishna, “Discrimination  of Normal, Benign, 
and Malignant Breast Tissues by Raman Spectroscopy,” Biopolymers, vol. 83, pp. 556–569, 2006. 
[22] M.-G. C. Pichardo-Molina J. L., Frausto-Reyes C., Barbosa-GarcÍa O., Huerta-Franco R., González-Trujillo J. L., 
RamÍrez-Alvarado C. A., and Gutiérrez-Juárez G., “Raman spectroscopy and multivariate analysis of serum samples 
from breast cancer patients,” Lasers in Medical Science, vol. 22, pp. 229–236, 2007. 
[23] N. Christodoulides, S. Mohanty, C. S. Miller, M. C. Langub, P. N., Floriano, P. Dharshan, M. F. Ali, B. Bernard, D. 
Romanovicz, E. Anslyn, P. C. Fox, and J. T. McDevitt, “Application of microchip assay system for the measurement 
of C-reactive protein in human saliva,” Lab on a Chip, vol. 5, no. 3, pp. 261–269, 2005. 
[24] R. Singla, B. Chambayil, A. Khosla, and J. Santosh, “Comparison of SVM and ANN for classification of eye events in 
EEG,” Biomedical Science and Engineering, vol. 4, pp. 62– 69, 2011. 
[25] S. Feng, S. Huang, D. Lin, G. Chen, Y. Xu, Y. Li, Z. Huang, J. Pan, R. Chen, and H. Zeng,  “Surface-enhanced 
Raman spectroscopy of saliva proteins for the noninvasive differentiation of benign and malignant breast tumors,” 
International Journal of  Nanomedicine, vol. 10, pp. 537–547, 2015. 
[26] S. Gonchukov, A. Sukhinina, D. Bakhmutov, and S. Minaeva, “Raman spectroscopy of saliva as a perspective method 
for periodontitis diagnostics,” Laser Physics Letters, vol. 9, no. 1, pp. 73–77, 2012 
GITHAIGA et al.                         |PHYSICS 
56 
[27] S. Mika, and K. Tsuda, “An Introduction to Kernel-Based Learning Algorithms,” IEEE Transactions on neural networks, 
vol. 12, no. 2, pp. 181–201, 2001. 
[28] S. Varghese, A. Reveendran, V. S. Kumar, K. Tm, and V. Ranganathan, “Micro Raman Spectroscopic Analysis on Blood 
Serum Samples of Ductal Carcinoma Patients,” Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 9, 
pp. 176–178, 2018. 
[29] T. Pfaffe, J. Cooper-white, P. Beyerlein, K. Kostner, and C. Punyadeera, “Diagnostic  Potential of Saliva: Current 
State and Future Applications,” Clinical Chemistry, vol. 57, no. 5, pp. 675-687, 2011.  
[30] W. L. Martinez and A. R. Martinez, Exploratory Data Analysis with MATLAB ®, London, United Kingdom: CRC Press, 
pp. 39, 42-49, 2005. 
[31] W. Wu, H. Gong, M. Liu, G. Chen, and R. Chen, “Noninvasive Breast Tumors Detection based on Saliva Protein 
Surface Enhanced Raman Spectroscopy and Regularized  Multinomial Regression,” 2015 8th International 
Conference on Biomedical Engineering and Informatics, no. 1, pp. 214-218, 2015. 
[32] Y. U. N. X. Ci, T. I. Y. U. Gao, J. U. N. Feng, and Z. Q. Guo, “Fourier Transform Infrared Spectroscopic Characterization 
of Human Breast Tissue: Implications for Breast Cancer,” Applied Spectroscopy, vol. 53, no. 3, pp. 312–315, 1999. 
[33] Y. Zhang, J. Sun, C. Lin, E. Abemayor, M. B. Wang, and D. Tw, “The Emerging Landscape of Salivary Diagnostics,” 
OHDM, vol. 13, no. 2, pp. 200–210, 2014. 
[34] Z. Movasaghi, S. Rehman, and I. U. Rehman, “Raman Spectroscopy of Biological Tissues,” Applied Spectroscopy 
Review, vol. 42, pp. 493–541, 2007. 
 
 
